-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A/WFX8fJ1YKM5YLzpDPn4G2XHYI2x4FZthhmnv0wbZBbPKUSvbaMAf4qvt42vjvh QEe6FWgPpFlr/8NO9+bVOQ== 0000950103-01-000106.txt : 20010212 0000950103-01-000106.hdr.sgml : 20010212 ACCESSION NUMBER: 0000950103-01-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010131 FILED AS OF DATE: 20010209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRAMED AMERICA INC CENTRAL INDEX KEY: 0000885988 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 061150326 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-20260 FILM NUMBER: 1529794 BUSINESS ADDRESS: STREET 1: ONE MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 BUSINESS PHONE: 9142538000 MAIL ADDRESS: STREET 1: 1 MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 FORMER COMPANY: FORMER CONFORMED NAME: IVF AMERICA INC DATE OF NAME CHANGE: 19950720 COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY DEAN WITTER & CO CENTRAL INDEX KEY: 0000895421 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] OTHER IRS NUMBER: 363145972 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 1585 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 2127614000 MAIL ADDRESS: STREET 1: 1585 BROADWAY STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: DEAN WITTER DISCOVER & CO DATE OF NAME CHANGE: 19960315 4 1 0001.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP FORM 4 [ ] Check this box if no longer OMB APROVAL subject to Section 16. Form 4 or OMB NUMBER: 3235-0287 Form 5 obligations may continue. Expires: September 30, 1998 See Instruction 1(b). Estimated average burden hours per response........0.5 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) 1. Name and Address of Reporting Person* Morgan Stanley Venture Capital III, Inc.(1) - ----------------------------------------------------------------------------- (Last) (First) (Middle) 1221 Avenue of the Americas - ----------------------------------------------------------------------------- (Street) New York NY 10020 - ----------------------------------------------------------------------------- (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol IntegraMed America, Inc. (INMD) - ----------------------------------------------------------------------------- 3. I.R.S. Number or Social Security of Reporting Person (Voluntary) - ----------------------------------------------------------------------------- 4. Statement for Month/Year 01/2001 - ----------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Day/Year) - ----------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner --- --- Officer (give title below) X Other (specify below) --- --- No longer a shareholder (2) - ---------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person - ---- X Form filed by More than One Reporting Person - ---- Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of Securities 6. Ownership 7. Nature of (Instr. 3) action action (A) or Disposed of Beneficially Owned Form: Direct Indirect Date Code (D) (Instr. 3, 4 at End of Month (D) or In- Beneficial (Instr.8) and 5) (Instr. 3 and 4) direct (I) Ownership (Month/ (Instr. 4) (Instr. 4) Day/ (A) or Year) Code V Amount (D) Price - ------------------------- --------- ---- --- ------- --- --------- -------------------- -------------- ------------- Common Stock 1/26/01 S 808,822(3) D $2.30 0
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). (Over) SEC 1475 (7-96) FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date Security of Derivative (Instr. 8) Securities (Month/Day/Year) (Instr. 3) Security Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Date Expiration Code V (A) (D) Exercisable Date - ------------------------------------------------------------------------------------------------------------------------------------ Warrants to purchase 1/26/01 S 60,000 Anytime 1/23/02 Common Stock 1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of Derivative Underlying Securities Derivative Derivative Form of Indirect Security (Instr. 3 and 4) Security Securities Derivative Beneficial (Instr. 3) (Instr. 5) Beneficially Security: Ownership Amount Owned at End Direct (D) (Instr. 4) or of Month or Indirect Number (Instr. 4) (I) of (Instr. 4) Title Shares - ------------------------------------------------------------------------------------------------------------------------------------ Warrants to purchase Common Stock 60,000 $2.30 0 Common Stock
Explanation of Responses: (1) Please see attached Joint Filer Information. (2) As of January 26, 2001, the Reporting Persons no longer own any shares of IntegraMed America, Inc. This is an exit filing. (3) On November 17, 1998, IntegraMed America, Inc. effected a 1-for-4 reverse stock split. /s/ Peter Vogelsang 2/9/01 - ---------------------------------------- ---------------- **Signature of Reporting Person Date By: Peter Vogelsang, authorized signatory for Morgan Stanley Dean Witter & Co. /s/ Debra Abramovitz - ---------------------------------------- **Signature of Reporting Person By: Debra Abramovitz, Vice President and Treasurer of Morgan Stanley Venture Capital III, Inc., the managing member of the general partner of the Funds **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 SEC 1474 (7-96) JOINT FILER INFORMATION Each of the following joint filers has designated Morgan Stanley Venture Capital III, Inc. ("MSVC III, Inc.") as the "Designated Filer" for purposes of the attached Form 4: (1) Morgan Stanley Dean Witter & Co. ("MSDW") 1585 Broadway New York, New York 10036 (2) Morgan Stanley Venture Partners III, L.L.C. ( "MSVP III, L.L.C.") 1221 Avenue of the Americas New York, New York 10020 (3) Morgan Stanley Venture Partners III, L.P. ("MSVP III, L.P.") 1221 Avenue of the Americas New York, New York 10020 (4) Morgan Stanley Venture Investors III, L.P. ("MSVI III, L.P.") 1221 Avenue of the Americas New York, New York 10020 (5) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P. ("MSVPEF, L.P.") 1221 Avenue of the Americas New York, New York 10020 MSVP III, L.P., MSVI III, L.P., and MSVPEF, L.P. are collectively referred to as the "Funds." Issuer & Ticker Symbol: IntegraMed (INMD) Date of Event Requiring Statement: 1/26/01 Signature: /s/ Peter Vogelsang ----------------------------------------------------------- By: Peter Vogelsang, as authorized signatory for MSDW Signature: /s/ Debra Abramovitz ----------------------------------------------------------- By: Debra Abramovitz, Vice President and Treasurer of MSVC III, Inc., the managing member of the General Partner of the Funds -----END PRIVACY-ENHANCED MESSAGE-----